Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CCR2 | P41597 | 3/20 | 0.42 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | CCR1 | P32246 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4896093 | 0.90 | KMT2A (0.46) | KMT2AKDM4EALDH1A1PLA2G1BATG4B | |
| SCHEMBL4887565 | 0.86 | SLC6A9 (0.43) | KMT2AKDM4EALDH1A1MEN1HPGD | |
| SCHEMBL4892547 | 0.84 | ALDH1A1 (0.40) | KMT2AKDM4EALDH1A1MEN1HPGD | |
| SCHEMBL4894897 | 0.83 | KMT2A (0.44) | KMT2AKDM4EALDH1A1MEN1HPGD | |
| SCHEMBL4887013 | 0.82 | KMT2A (0.40) | KMT2AKDM4EALDH1A1PLA2G1BATG4B | |
| SCHEMBL4893181 | 0.79 | THRB (0.43) | KMT2AKDM4EALDH1A1MEN1SMN1; SMN2 | |
| SCHEMBL4883922 | 0.79 | RAB9A (0.50) | KMT2AALDH1A1MEN1HPGDSMN1; SMN2 | |
| SCHEMBL4882730 | 0.79 | THRB (0.42) | KMT2AKDM4EALDH1A1MEN1 | |
| SCHEMBL4892647 | 0.73 | KDM4E (0.45) | KMT2AKDM4EALDH1A1MEN1HPGD | |
| SCHEMBL4892456 | 0.73 | THRB (0.38) | KMT2AKDM4EALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080200512-A1 | Hepatitis C virus polymerase inhibitors | BLANEY JEFFREY MARK | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200512-A1 | Hepatitis C virus polymerase inhibitors | SSU72, POLR2H, POLR2E | KMT2A 2650/4885CCR2 741/4885GPR139 2236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.